Mydecine Innovations Group Inc. announced that it has entered into a subscription agreement for private placement of 326,666 common shares at a price of CAD 0.75 per share for gross proceeds of CAD 244,999.50 with a third-party investor on August 15, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0183 USD | +63.02% | +64.86% | +22.82% |
01/05 | Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding | CI |
23/02 | Mydecine Innovations Closes Partial Debt Settlement | MT |
1st Jan change | Capi. | |
---|---|---|
+22.82% | 694K | |
+27.44% | 48.16B | |
-1.04% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.10% | 25.59B | |
-22.90% | 18.96B | |
+7.88% | 12.92B | |
+29.25% | 12.03B | |
-2.26% | 11.77B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. announced that it expects to receive CAD 0.245 million in funding